Based on ratings from 4 stock analysts, the TG Therapeutics Inc stock price is expected to increase by 122.33% in 12 months. This is calculated by using the average 12-month stock price forecast for TG Therapeutics Inc. The lowest target is $22.00 and the highest is $45.00. Please note analyst price targets are not guaranteed and could be missed completely.
About 4 Wall Street analysts have assignedTGTX 4 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect TG Therapeutics Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on TGTX. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
eric joseph J.P. Morgan | Buy | $22.0 | maintained | Feb 3, 2024 |
mayank mamtani B.Riley Financial | Buy | $29.0 | reiterated | Feb 2, 2024 |
matthew kaplan Ladenburg Thalmann & Co. | Buy | $39.0 | maintained | Jan 16, 2024 |
edward white H.C. Wainwright | Buy | $45.0 | reiterated | Jan 11, 2024 |
andrea tan Goldman Sachs | Hold | None | reiterated | Jan 9, 2024 |
corinne jenkins Goldman Sachs | Hold | None | maintained | Nov 1, 2023 |
alec stranahan Bank of America Securities | Sell | $6.0 | reiterated | Nov 1, 2023 |
prakhar agrawal Cantor Fitzgerald | Buy | $30.0 | maintained | Aug 1, 2023 |
roger song Jefferies | Buy | $40.0 | rated | Jun 24, 2023 |
joshua schimmer Evercore ISI | Buy | $38.0 | maintained | May 1, 2023 |
chris howerton Jefferies | Buy | $25.0 | maintained | Feb 8, 2023 |
peter lawson Barclays | Buy | $15.0 | maintained | Mar 5, 2019 |
madhu kumar Goldman Sachs | Buy | $10.0 | reiterated | Oct 12, 2018 |
reni benjamin JMP Securities | Buy | $22.0 | maintained | Aug 14, 2018 |
matthew andrews Jefferies | Buy | $23.0 | maintained | Feb 5, 2018 |
yatin suneja Guggenheim | Buy | None | rated | Oct 18, 2017 |
andrew fein H.C. Wainwright | Buy | $18.0 | reiterated | Mar 7, 2017 |
jason wittes Loop Capital Markets | Buy | $26.0 | initiatedcoverage | Feb 22, 2017 |
joseph pantginis H.C. Wainwright | Buy | $33.0 | reiterated | Dec 7, 2016 |
jonathan aschoff Roth Capital | Buy | $28.0 | reiterated | Aug 9, 2016 |
In 2023, TGTX generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that TGTX's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SOFI-USD
$8.33
TMUS-USD
$161.76
TXN-USD
$162.4
UPST-USD
$33.9
$27.88
TXG-USD
$49.11